Efficacy of consensus interferon alpha against HSV-2 infections.
D015088:2',5'-Oligoadenylate Synthetase / Q000378:metabolism; D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003602:Cytotoxicity, Immunologic; D004274:DNA, Recombinant; D005260:Female; D006561:Herpes Simplex / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000235:genetics / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D008647:Mesocricetus; D011994:Recombinant Proteins; D018139:Simplexvirus / Q000254:growth & development*
D004274:DNA, Recombinant; D007370:Interferon Type I; D011994:Recombinant Proteins; D015088:2',5'-Oligoadenylate Synthetase